Finnish national focal point

The national focal point is hosted by the Finnish Institute for Health and Welfare (THL). The Finnish Institute for Health and Welfare (THL) is an independent state-owned expert and research institute that promotes the welfare, health and safety of the population.
News
Events, meetings and visits
- Potent synthetic substances, new drug mixtures and changing patterns of use pose growing threat in Europe
- Coming soon: European Drug Report 2024 to be released on 11 June
- Celebrating European Day of Languages: EMCDDA multilingual drug glossary unveiled
- Reitox network meets to showcase 2022 highlights, new digital resources and plan future activities
- 25 years of early warning and response to new psychoactive substances in Europe
- Penalties for drug law offences in Europe ‘at a glance’ — new countries added to online tool
Events
Events, meetings and visits
- Prevalence and patterns of drug use expert meeting 2025 (08.04.2025 to 09.04.2025, Lisbon, Portugal)
- Reitox academy on drug checking (03.10.2024 to 04.10.2024, Utrecht, The Netherlands)
- Lisbon Addictions 2024 (23.10.2024 to 25.10.2024, Lisbon, Portugal)
- Reitox Academy on ‘Implementing futures/foresight in the drug field, with a focus on synthetic drugs’ (27.06.2024 to 28.06.2024, Dublin, Ireland)
- 70th Heads of Reitox national focal points meeting (21.05.2024 to 23.05.2024, Lisbon, Portugal)
- Launch event: European Drug Report 2024 (11.06.2024, Online)
Publications
Publications related to this partner

This data factsheet presents insights from the European Web Survey on Drugs 2024. It provides an overview of key data from 61 732 individuals aged 18 or older who use drugs and live in one of 24 EU countries or Norway.

This page presents a selection of the main achievements of 2024 as highlighted by our partners from the Reitox network of national focal points. This information was prepared and published specifically for the Lisbon Addictions 2024.

This page brings together some of the most frequently asked questions about the Reitox network, how it functions, who are Reitox members and how to cooperate with, or participate in the network. Further details can be found via the websites and other links provided at the end of this page.

Drug-induced deaths are those that are directly attributable to the use of drugs. On this page, you can find the latest analysis of drug-induced deaths in Europe, including key data on overdose deaths, substances implicated and more.

People who inject drugs are at risk of contracting infections through the sharing of drug use paraphernalia. On this page, you can find the latest analysis of drug-related infectious diseases in Europe, including key data on infections with HIV and hepatitis B and C viruses.

Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. On this page, you can find the latest analysis of harm reduction interventions in Europe, including key data on o
Document library
Relevant external documents or commissioned reports from the EMCDDA Document library
- Prevalence and patterns of drug use expert meeting 2025 ( )
- European Web Survey on Drugs 2024: top-level findings, 24 EU countries and Norway ( )
- EU Commission (2023) EU Roadmap to fight Drug Trafficking and Organised Crime ( )
- Ministry of Health, Ministry of Justice, Luxembourg (2023) Pilot project for legal access to cannabis for non-medical purposes ( )
- Pro Facto (2023) Exploratory research, Possibilities for monitoring the consequences of the application of the Damocles Act in the Netherlands ( )
- RAND Corporation, Breuer Intraval and Trimbos-instituut (2024) Controlled Cannabis Supply Chain Experiment study, baseline report 2022 ( )
Media library
Related photos, infographics and videos from our Media library
Contact information
Finnish Institute for Health and Welfare
Ms Marja Liisa Helminen
Helsinki
Finland